One year after stepping down as founding director of the US National Center for Advancing Translational Science (NCATS) to join Flagship Pioneering as CEO-partner, Christopher Austin has been named ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Vesalius Therapeutics, a ...

It’s no secret that drugs don’t work equally well for everyone. Doug Cole, chairman and co-founder of Vesalius Therapeutics, saw these limitations while he was a practicing physician in the 1990s.

Researchers at VCU Massey Comprehensive Cancer Center have developed a new computational tool called Vesalius, which could help clinicians understand the complex relationships between cancer cells and ...